Raynaud Phenomenon
📧 Sign up to get email alerts when something new happens for Raynaud Phenomenon.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Open Label Treprostinil Raynaud's Study [Phase 4]
Open-label Phase 4 clinical trial of treprostinil for Raynaud's disease/phenomena is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Multi-modal Quantitative Imaging of the Skin
Clinical trial update for a multi-modal quantitative imaging study of the skin, sponsored by HJN Sverige AB/Neko Health, currently recruitin…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Evaluation of Botulinum TOXin Type a in the Treatment of Buerger's Disease [Phase 3]
Phase 3 clinical trial evaluating botulinum toxin type A for Thromboangiitis Obliterans (Buerger's disease) and Raynaud phenomenon; the stud…
-
CLINICAL_TRIALS research · 2016-06-02Clinical Trial Update: Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis. [NA]
This completed clinical trial evaluates whether laser speckle contrast imaging can detect cutaneous microvascular dysfunction in systemic sc…
-
CLINICAL_TRIALS research · 2015-12-09Clinical Trial Update: PORH and Response to Cold in Raynaud's Phenomenon. [NA]
A clinical trial update investigating PORH (post-occlusive reactive hyperemia) and response to cold in Raynaud's phenomenon; the current stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-02-05Clinical Trial Update: Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's Phenomenon [Phase 1, Phase 2]
Phase 1/2 clinical trial to evaluate the safety and efficacy of Neovasculgen for secondary Raynaud's phenomenon; the status is unknown based…
-
CLINICAL_TRIALS research · 2010-07-20Clinical Trial Update: Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms [Phase 3]
Phase 3 clinical trial update for a topical formulation aimed at treating and preventing Raynaud's phenomenon symptoms; current status is un…